Imagine every virus has its own unique musical note or 'song' based on how it shakes. This technology uses special lasers to listen to those vibrations to identify exactly which virus is present. It's like using a digital tuning fork to spot a germ in minutes without needing complex chemical labels.
Current viral diagnostics can be slow and often require specific labels or known markers. This delays patient treatment and the ability to respond to unknown pandemic threats.
A proof-of-concept system using Raman and Brillouin spectroscopy and AI to identify viruses. A faster slow-frequency Raman microscope has already been developed.
If you are a diagnostics company dealing with slow turnaround times for viral tests — this project developed a light-scattering method that identifies viral particles in a few minutes. This allows for rapid patient isolation and treatment at the earliest stage.
If you are a biotech firm dealing with inefficient antibody screening — this project developed a way to monitor the vibratory fingerprint of antibodies. This enables rapid determination of binding efficiency for drug discovery.
If you are a screening provider dealing with the need to detect unknown viruses during pandemics — this project developed a label-free detection technology. It can identify viral particles even when the specific virus is previously unknown.
Based on available project data, the technology is designed to be accessible to most people because of its ease of implementation and cost, though specific price points are not listed.
The project is currently developing a proof of concept. Based on available project data, it aims for high selectivity and sensitivity down to single viral particles, which are key requirements for industrial scaling.
Based on available project data, the project is in the early stages with a first publication accepted regarding a fast Raman microscope; specific licensing terms are not yet provided.
The technology is designed to identify viral particles in a matter of minutes.
Artificial intelligence is used to correlate vibrational spectra with the physical properties of the virus to facilitate identification.
The consortium is research-heavy with 5 universities and 2 research institutes, but it maintains a 22% industry ratio with 2 SMEs. This structure suggests a transition from fundamental physics (light scattering) to commercial application, supported by a diverse geographic spread across 5 countries including France, Germany, and Spain.
Contact UNIVERSITE LYON 1 CLAUDE BERNARD
Contact us to track the development of this viral sensing prototype.
